Clinical Trials Browser

Interventional × Substance Withdrawal Syndrome × Dasatinib × Clear all

NCT04147533 2024-11-26

HALF

Phase 2 Active not recruiting

Other hematologic neoplasm

Substance Withdrawal Syndrome, Leukemia, Myeloid, Chronic-Phase